Replicor: leading the fight against hepatitis B and D
Over 80% of those who contract hepatitis B virus (HBV) recover from the disease, but some 350 million people worldwide are not able to control the virus and develop chronic infection that can seriously damage the liver — over 750,000 people die from complications every year.
No comments yet.